CureVac NV (CVAC)
3.89
+0.12
(+3.18%)
USD |
NASDAQ |
May 31, 16:00
3.88
-0.01
(-0.26%)
After-Hours: 20:00
CureVac Accounts Payable (Quarterly): 19.93M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.93M |
| December 31, 2023 | 51.25M |
| September 30, 2023 | 13.31M |
| June 30, 2023 | 14.58M |
| March 31, 2023 | 16.33M |
| December 31, 2022 | 73.19M |
| September 30, 2022 | 51.71M |
| June 30, 2022 | 50.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 70.77M |
| December 31, 2021 | 138.43M |
| September 30, 2021 | 69.92M |
| June 30, 2021 | 91.12M |
| December 31, 2020 | 21.68M |
| September 30, 2020 | 58.97M |
| March 31, 2020 | 6.704M |
| December 31, 2019 | 5.972M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.972M
Minimum
Dec 2019
138.43M
Maximum
Dec 2021
47.16M
Average
50.96M
Median
Accounts Payable (Quarterly) Benchmarks
| BioNTech SE | 322.67M |
| Affimed NV | 20.91M |
| InflaRx NV | 8.216M |
| MorphoSys AG | 31.38M |
| Immatics NV | 6.567M |